Platforms and Units
Platforms and Units
Platforms and Units
IBG-PHARMA Platform
IBG-Biobank Platform
Drug Analysis and Control Lab.
Vivarium Unit
Zebrafish Facility
Business Development and Commercialization Unit
NEVCELL

Business Development and Commercialization Unit

The Business Development and Commercialization Unit, operating under the Izmir Biomedicine and Genome Center (IBG), coordinates strategic processes that transform the knowledge, technologies, and capabilities developed at the Center into societal and economic value. The unit reports to the Deputy Director responsible for Business Development and Commercialization within the organizational structure and plays an active role at every stage of the journey from research to product.

Our Services and Areas of Support

iş geliştirmeAwareness and Training: Planning and delivering training, seminars, and information sessions to raise awareness among researchers on project development, commercialization, and entrepreneurship.

iş geliştirmeProject Development and Management: Providing preparation, coordination, and management services for projects targeting national and international funding sources.

iş geliştirmeCollaboration and Network Management: Planning and managing strategic collaboration processes with public institutions, private sector organizations, and non-governmental organizations.

iş geliştirmeIntellectual Property Management: Protecting intellectual property rights for inventions developed at IBG, managing patent applications and IP portfolios.

iş geliştirmeCommercialization Strategies: Implementing technology transfer, licensing, co-development models, and industry engagement strategies.

iş geliştirmeEntrepreneurship Support: Offering mentorship, guidance, and support for researchers in entrepreneurship and spin-off creation processes.

With its dynamic structure supporting the transformation of innovative research into economic and societal impact, the IBG Business Development and Commercialization Unit serves as a reliable bridge for both IBG researchers and external stakeholders.